Related references
Note: Only part of the references are listed.Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications
Francis Boateng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Nuclear Uptake of Gold Nanoparticles Deduced Using Dual-Angle X-Ray Fluorescence Mapping
Aaron McCulloch et al.
PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION (2019)
Unraveling the cell-type dependent radiosensitizing effects of gold through the development of a multifunctional gold nanoparticle
James R. Nicol et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials
Yasir Alayed et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
Sigrid A. Langhans
FRONTIERS IN PHARMACOLOGY (2018)
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer The NRG Oncology RTOG 0126 Randomized Clinical Trial
Jeff M. Michalski et al.
JAMA ONCOLOGY (2018)
Enhanced nanoparticle delivery exploiting tumour-responsive formulations
Lindsey A. Bennie et al.
CANCER NANOTECHNOLOGY (2018)
Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer
Cian M. McCrudden et al.
CANCER NANOTECHNOLOGY (2018)
Histidine-enriched multifunctional peptide vectors with enhanced cellular uptake and endosomal escape for gene delivery
Zhao Meng et al.
JOURNAL OF MATERIALS CHEMISTRY B (2017)
A mechanistic study of gold nanoparticle radiosensitisation using targeted microbeam irradiation
Mihaela Ghita et al.
SCIENTIFIC REPORTS (2017)
Biological mechanisms of gold nanoparticle radiosensitization
Soraia Rosa et al.
CANCER NANOTECHNOLOGY (2017)
Embedded Spheroids as Models of the Cancer Microenvironment
Kristie M. Tevis et al.
ADVANCED BIOSYSTEMS (2017)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
David Dearnaley et al.
LANCET ONCOLOGY (2016)
A comparison of gold nanoparticle surface co-functionalization approaches using Polyethylene Glycol (PEG) and the effect on stability, non-specific protein adsorption and internalization
Emma Harrison et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2016)
Potentiating the Anticancer Properties of Bisphosphonates by Nanocomplexation with the Cationic Amphipathic Peptide, RALA
Ashley S. Massey et al.
MOLECULAR PHARMACEUTICS (2016)
Preclinical evaluation of gold-DTDTPA nanoparticles as theranostic agents in prostate cancer radiotherapy
Karl T. Butterworth et al.
NANOMEDICINE (2016)
Optimising element choice for nanoparticle radiosensitisers
Stephen J. McMahon et al.
NANOSCALE (2016)
Dual Action Enhancement of Gold Nanoparticle Radiosensitization by Pentamidine in Triple Negative Breast Cancer
Sohyoung Her et al.
RADIATION RESEARCH (2016)
Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy
Neil Mariados et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
RALA-mediated delivery of FKBPL nucleic acid therapeutics
Rachel Bennett et al.
NANOMEDICINE (2015)
Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?
Pedro Pedrosa et al.
NANOMATERIALS (2015)
Pelvic radiation disease: Updates on treatment options
Leonardo Frazzoni et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2015)
EANM’14
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery
Helen O. McCarthy et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial
David P. Dearnaley et al.
LANCET ONCOLOGY (2014)
Multicellular Tumor Spheroids for Evaluation of Cytotoxicity and Tumor Growth Inhibitory Effects of Nanomedicines In Vitro: A Comparison of Docetaxel-Loaded Block Copolymer Micelles and Taxotere®
Andrew S. Mikhail et al.
PLOS ONE (2013)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial
David Dearnaley et al.
LANCET ONCOLOGY (2012)
Cell-penetrating peptides: breaking through to the other side
Erez Koren et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Uptake of Gold Nanoparticles in Healthy and Tumor Cells Visualized by Nonlinear Optical Microscopy
Gianluca Rago et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2011)
Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy
K. T. Butterworth et al.
NANOTECHNOLOGY (2010)
Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics
Frederic Heitz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Gold Nanoparticles of Diameter 1.4 nm Trigger Necrosis by Oxidative Stress and Mitochondrial Damage
Yu Pan et al.
SMALL (2009)
Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study
SH Cho
PHYSICS IN MEDICINE AND BIOLOGY (2005)
Cell-penetrating peptides: tools for intracellular delivery of therapeutics
S Deshayes et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
The use of gold nanoparticles to enhance radiotherapy in mice
JF Hainfeld et al.
PHYSICS IN MEDICINE AND BIOLOGY (2004)
Share Paper
